Factors associated with the difference in HbA1c and FreeStyle Libre Glucose management indicator (GMI) in patients with type 1 diabetes

Priya Sarkar1, Manushri Jain1,2, Tejas Kalaria2, Brett Healey1, Rajeev Raghavan1, Rousseau Gama2

1 Diabetes and Endocrinology, New Cross Hospital, Royal Wolverhampton NHS Trust, Wolverhampton WV10 0QP

2 Clinical Biochemistry, New Cross Hospital, Black Country Pathology Services, Royal Wolverhampton NHS Trust, Wolverhampton WV10 0QP

Implementation of Joint Society Guidance on Diabetes (COVID:Diabetes): Dexamethasone/Glucocorticosteroid Therapy In Covid-19 Patients during the COVID-19 Pandemic in a District General Hospital

G Roulston; J Harding J; R Harper; CM McHenry; E McKeever; P McMullan

Ulster Hospital, South Eastern Health and Social Care Trust, Dundonald, Belfast

Review: Environmental determinants of type 1 diabetes -> From association to causality

Lauren M. Quinn1, F.S. Wong2, P. Narendran1

1 Institute of Immunology and Immunotherapy, Research College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK 2 Diabetes Research Group, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK

Glycaemic tracking of HbA1c in patients with type 1 diabetes can be modified through intensive diabetes support regardless of diabetes duration

Lauren M. Quinn1, R. Thayakaran2, N. Thomas2, K. Nirantharakumar 2, P. Narendran 3,4

1 Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK
2 Public Health, Epidemiology and Biostatistics, Institute of Applied Health Research, University of Birmingham, Birmingham, UK
3 Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK
4 Department of Diabetes, University Hospitals of Birmingham, Birmingham, UK

Subscribe to The Association of British Clinical Diabetologists